Clinical Trial Update: A Proof-of-Concept Study of AC-201 to Prevent Gout Flares [Phase 2]

View source ↗

Summary

A Phase 2 proof-of-concept trial of AC-201 to prevent gout flares has completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• AC-201

Snippet

Sponsor: TWi Biotechnology, Inc. | Conditions: Gout Flares | Phase 2 | Status: COMPLETED | Results posted: 2014-12-01